Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1965-1969, May 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ealovega, M. W.
Right arrow Articles by Wicha, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ealovega, M. W.
Right arrow Articles by Wicha, M. S.

bcl-xs Gene Therapy Induces Apoptosis of Human Mammary Tumors in Nude Mice1

Mark W. Ealovega, Patrick K. McGinnis, Venil N. Sumantran, Michael F. Clarke and Max S. Wicha2

Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109-0724

Bcl-xs is a dominant negative repressor of Bcl-2 and Bcl-xL, both of which inhibit apoptosis. We used a replication-deficient adenoviral vector to transiently overexpress Bcl-xs in MCF-7 human breast cancer cells, which overexpress Bcl-xL. Infection with this vector induced apoptosis in vitro. We then determined the effects of intratumoral injection of bcl-xs adenovirus on solid MCF-7 tumors in nude mice. Tumors injected four times with the bcl-xs adenovirus showed a 50% reduction in size. Using terminal transferase-mediated dUTP-digoxigenin nick end labeling, we observed apoptotic cells at sites of bcl-xs adenoviral injection. These experiments demonstrate the feasibility of using bcl-xs gene therapy to induce apoptosis in human breast tumors.

1 This research was supported by NIH Grants CA-61777 and CA-64556 and American Cancer Society Grant BE-161C.

2 To whom requests for reprints should be addressed, at University of Michigan Comprehensive Cancer Center, 102 Observatory Street, Ann Arbor, MI 48109-0724.

Received 1/18/96. Accepted 3/15/96.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. J. Suzuki, H. Nagase, C. M. Wong, S. V. Kumar, V. Jain, A.-M. Park, and R. M. Day
Regulation of Bcl-xL Expression in Lung Vascular Smooth Muscle
Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 678 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot
Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x
J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
T. Braun, S. Dar, D. Vorobiov, L. Lindenboim, N. Dascal, and R. Stein
Expression of Bcl-xS in Xenopus Oocytes Induces BH3-Dependent and Caspase-Dependent Cytochrome c Release and Apoptosis
Mol. Cancer Res., January 1, 2003; 1(3): 186 - 194.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. R. Mercatante, J. L. Mohler, and R. Kole
Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents
J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone
Apoptosis: Target of Cancer Therapy
Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. N. Sumantran, D. S. Lee, V. V. Baker, S. Murray, M. Strawderman, and M. S. Wicha
A Bcl-xS Adenovirus Demonstrates Therapeutic Efficacy in an Ascites Model of Human Breast Cancer
Reproductive Sciences, May 1, 2000; 7(3): 184 - 189.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
S. W. Lowe and A. W. Lin
Apoptosis in cancer
Carcinogenesis, March 1, 2000; 21(3): 485 - 495.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Fridman, M. A. Benedict, and J. Maybaum
bcl-Xs-induced Cell Death in 3T3 Cells Does Not Require or Induce Caspase Activation
Cancer Res., December 1, 1999; 59(23): 5999 - 6004.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. S. Chang, A. Kelekar, M. H. Harris, J. E. Harlan, S. W. Fesik, and C. B. Thompson
The BH3 Domain of Bcl-xS Is Required for Inhibition of the Antiapoptotic Function of Bcl-xL
Mol. Cell. Biol., October 1, 1999; 19(10): 6673 - 6681.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Lazennec, J. L. Alcorn, and B. S. Katzenellenbogen
Adenovirus-Mediated Delivery of a Dominant Negative Estrogen Receptor Gene Abrogates Estrogen-Stimulated Gene Expression and Breast Cancer Cell Proliferation
Mol. Endocrinol., June 1, 1999; 13(6): 969 - 980.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. R. Mercatante, C. D. Bortner, J. A. Cidlowski, and R. Kole
Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells. ANALYSIS OF APOPTOSIS AND CELL DEATH
J. Biol. Chem., May 4, 2001; 276(19): 16411 - 16417.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.